Stevens Institute of Technology Opens Biotechnology and Drug–Discovery Laboratory

Article

The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.

The Center for Healthcare Innovation at Stevens Institute of Technology will open its Biotechnology and Drug-Discovery Laboratory in January 2014 as a new biotechnology and drug discovery enterprise that will partner with other Stevens faculty, students, and external academic and industry collaborators. Established in part with a donation of equipment and supplies from Hoffmann-La Roche and support from the New Jersey Department of Labor, seven former Roche personnel recently joined Stevens as faculty and researchers in this new initiative. Laboratory staff also includes three new professors with R&D experience in pharmaceutical and biotechnology corporate laboratories. The laboratory will serve as a center for research in the areas of preclinical gene cloning and purification of therapeutic proteins, assay development, and robotic drug screening.

Source: Stevens Institute of Technology

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.